Quantum FinTech Acquisition Corporation (NYSE: QFTA) announced this morning that its shareholders approved its combination with AtlasClear at a special meeting held on Friday.
At the meeting, stockholders holding 4,953,369 shares out of a possible 5,050,384 shares of Quantum’s common stock exercised their right to redeem their shares.
Although the final amount of funds to be removed from the trust is still being calculated by the trustee, it is expected that approximately $53.1 million, or $10.73 per share, will be removed from the trust. This means that the SPAC will have just 97,015 shares remaining.
Originally, the parties had set a minimum cash requirement of $40 million at the time of the deal announcement without a PIPE. However, two weeks ago, they decided to waive this condition, anticipating that it would facilitate a successful closing.
The SPAC did not give a definitive timeline for when the deal will close, but stated it will be completed as soon as practicable following the satisfaction or waiver of the remaining closing conditions, including the condition that the common stock will be approved for listing on the NYSE American.
Following the closing, the combined company is expected to begin trading on the NYSE American under the symbol “ATCH”.
Quantum FinTech inked its deal with AtlasClear in November 2022, which is itself combining with correspondent clearing broker-dealer Wilson Davis & Co. and acquiring Commercial Bancorp of Wyoming.
All other proposals presented on the ballot were approved by shareholders.
Cantor Equity Partners III Inc. (NASDAQ:CAEP) announced the pricing of its upsized $240 million IPO and its shares are expected to begin trading on the Nasdaq under the symbol “CAEP”, Thursday, June 27, 2025. The new SPAC plans to combine with a target company in an industry where its management has relevant expertise such financial...
Launch One (NASDAQ:LPAA) has entered into a definitive agreement to combine with biotech firm Minovia Therapeutics at a $180 million pre-money valuation. Haifa, Israel-based Minovia is developing a drug platform based on mitochondrial cell therapies to potentially treat rare disorders as well as the effects of aging and other causes of bodily degeneration. The combined...
CEO Marc Nemati and Colombier II’s Omeed Malik break down the deal and the strategy. Despite its moniker as the “the everything store” you can’t buy everything on Amazon, and firearms are one of those things. But, GrabAGun has spent years building a platform for regulated online firearms purchases, and soon, consumers will be able...
At the SPAC of Dawn Futures remain green after Fed Chairman Jerome Powell hinted at a July rate cut and tensions cooled for now in the Middle East. That has not warmed all corners of the SPAC market as teams continue to hit bumps in their shareholder votes this week. Four Leaf (NASDAQ:FORL) was the...
Lightwave Acquisition Corp. (NASDAQ:LWACU) announced the pricing of its $187.5 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “LWACU”, Wednesday, June 25, 2025. The new SPAC plans to combine with a technology target or another industry that complements its management team’s background. Lightwave’s management team is led...